Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 28;10(17):3867.
doi: 10.3390/jcm10173867.

New Indications for Liver Transplantation

Affiliations
Review

New Indications for Liver Transplantation

Alberto Zanetto et al. J Clin Med. .

Abstract

Liver transplantation (LT) is an important therapeutic option for the treatment of several liver diseases. Modern LT is characterized by remarkable improvements in post-transplant patient survival, graft survival, and quality of life. Thanks to these great improvements, indications for LT are expanding. Nowadays, clinical conditions historically considered exclusion criteria for LT, have been considered new indications for LT, showing survival advantages for patients. In this review, we provide an updated overview of the principal newer indications for LT, with particular attention to alcoholic hepatitis, acute-on-chronic liver failure (ACLF), cholangiocarcinoma and colorectal cancer metastases.

Keywords: acute-on-chronic liver failure; alcoholic hepatitis; cholangiocarcinoma; colorectal cancer metastases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
New indications for liver transplantation. Controversial indications include severe alcoholic hepatitis and ACLF grade 3. Questionable indications include non-hepatocellular carcinoma liver cancer, and liver metastases from colorectal cancer. CCA: cholangiocarcinoma; ACLF: acute-on-chronic liver failure.

References

    1. Starzl T.E., Marchioro T.L., Porter K.A., Brettschneider L. Homotransplantation of the liver. Transplantation. 1967;5:790–803. doi: 10.1097/00007890-196707001-00003. - DOI - PMC - PubMed
    1. Adam R., Karam V., Cailliez V., Grady J.G.O., Mirza D., Cherqui D., Klempnauer J., Salizzoni M., Pratschke J., Jamieson N., et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR)—50-year evolution of liver transplantation. Transplant. Int. 2018;31:1293–1317. doi: 10.1111/tri.13358. - DOI - PubMed
    1. Mathurin P., Bataller R. Trends in the management and burden of alcoholic liver disease. J. Hepatol. 2015;62:S38–S46. doi: 10.1016/j.jhep.2015.03.006. - DOI - PMC - PubMed
    1. Burra P., Senzolo M., Adam R., Delvart V., Karam V., Germani G., Neuberger J. Liver transplantation for alcoholic liver disease in Europe: A study from the ELTR (European Liver Transplant Registry) Am. J. Transplant. 2010;10:138–148. doi: 10.1111/j.1600-6143.2009.02869.x. - DOI - PubMed
    1. Singal A.K., Guturu P., Hmoud B., Kuo Y.F., Salameh H., Wiesner R.H. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755–760. doi: 10.1097/TP.0b013e31827afb3a. - DOI - PubMed

LinkOut - more resources